Two Companies or the Same: Active vs. Not-Active

When search/listing clients to include Non-Active Accounts set the option:
Search ALL [Active & Not-Active].

By default the Client search only lists Active accounts.  If the search turns up no results or it appears that an accounts is missing, it’s possible the account is Not-Active.  To enable the search to return Active and Not-Active clients, set the search attribute as shown in the example below.

You can cycle through the options (Active, Not-Active, All) by tapping on the circular arrows icon  that precedes each of the search options.

This example searches for a client whose name starts with Zone, and finds two with similar names.  The first one is account no. 368, and the second one is account no. 369.  Account numbers are assigned sequentially, so account no. 369 was probably entered accidentally, and when the user noticed it was a duplicate, it was made Not-Active.

**Note: when double asterisks (**) precede the client name it means the client is not-active and when double asterisks (**) precede the account name it means the account is not-active.  A Client can have multiple accounts and some of its accounts can be Not-Active while the Client is Active.

Any client representative, company contacts, that belong to the not-active account would not be able to login to the portal.

Random Selection Annual Statistics

For a consortium or a stand alone pool, a statistics report showing the percentage of participants selected and the percentage of tests collected for both the drug and alcohol test.  The percentages are based on the average number of participants who participated in random selections for the year specified.

For a consortium report, choose the consortium in the drop down on the main screen and click the report icon  to the right.  For a stand alone pool, search for the company and tap its report icon .

On the report page, set the year for the report:

Further down the page, tap the report:

The report shows the percentage selected and collected for each random selection for the year specified.
There are four columns of numbers. Under the first column, Substance, the displayed values reflect the number of participants selected (accumulating with each random) and the percentage collected.  The second column, Collected, represents the number of tests collected and the corresponding percentage.  The two columns for the alcohol test report the number selected and percentages similarly as for the substance test.

Periodically through the year you can send a report to all clients regarding their random selection tests that have not yet been reported as collected and the results of each.  On the main page, tap the results menu. From the results page, tap the option 10.a NOT Collected (it conveniently presents a year to select – the report page will provide more options if needed).

For 2025, below you will find an example of the NOT Collected report.
Tap the email icon (outlined in red) to send an email report to every company. Or tap the email icon for each account to send it individual to the contact.  Every account requires a Random Coordinator (someone assigned to the account and mark as Random Coordinator).  Click the open icon on each line to see the tests (substance and/or alcohol) that have not been completed.  Tap the option List ALL by Company (immediately under the red outlined email option) to see a list of all uncollected tests with the participant’s name, their company, and the tests that have not been collected; substance and/or alcohol.

Email Random Selections to Company Contacts

When a random selection is completed, the page that shows the results of the selection provides options for a number of administrative reports, printed reports for the client and options to email the company contact.

The user can reopen that page for any previously generated random.  On the main page click the Randoms shortcut icon:

When the page opens enter the calendar period when the random was generated and click the List Randoms button to list the randoms for the period specified as shown below.  To open the random selection and review the participants selected and all the print options, click the first icon outlined in red below.  From that page you can also choose the option to send an email to the company.  To open the email page directly from the list below, click the second icon outlined in red.

Send the emailing: When you click the email option (second icon outlined in red above) the email control page will open with a list of contacts for the company.  To send an email to the listed contact be sure their check-box is checked as shown below and click the email button (outlined in red below).

A new page opens with the message you can change to suit your communication style. There is no need to address the contact specifically – the email module will add their name to the salutation.  The email page will allow you to enter your preferred greeting, e.g., Dear, and the email, in this example, when the email is sent, it would automatically say: Dear Deborah Webb.

After you review the message, and other options on the email page, click the proof button at the bottom on the left.  The proof page will provide a preview of the email.  At the bottom of the proof page, on the left, click the button: Send eMail(s), and you’re done.  The user will also get a copy of the email send.

Generate a Random from a Single Account

To generate a random selection from the participants in a single account, as a “stand alone pool” (not a consortium of multiple companies):  in this example click the random selection icon  for Janatorial Staff:

This will open the random selection control where you enter the number of participants you want for a drug test and the number you want for an alcohol test if you need to select for both.

In the example below, 3 participants will be selected for a [Urine] drug test and 1 participant for an alcohol [Breath] test. The lab panel will be set as the NIDA-5 (standard FMCSA 5-Panel).  Don’t forget to enter the Reference (First Quarter, Second Quarter, etc.).  Below the section shown below, click the button Generate the Random.

DrugTestNetwork/RandomWare features comprehensive random selection utilities to pick participants for drug and alcohol testing to comply with drug free workplace policies or to stay in compliance with US DOT (Department of Transportation) regulations.  The application features resources to generate random selections from stand alone pools or a consortium of multiple companies. Specify annual percentage targets, for stand alone pools or consortia, and the the random selection control will automatically keep the selections on track so you will hit the annual target of participants required for both the drug and the alcohol tests.

List Participants Selected in Previous Random

To list a company’s participants selected in earlier random selections:

  • Search for the company
  • Click the List Randoms icon for the account:

When the list random page opens, enter the dates that cover the period the random selections were generated.  The example below shows random selections for 2025 for the account LB Cargo, and each random was conducted for the consortium named FMCSA Consortium:

To open the list of participants selected for the random generated on 12/08/2025, click the Open icon .

When the page opens it will all the participants selected from the account. In this case, it will only include the paricipants selected for the account and not the full list of participants from all members of the consortium. To print the page type [Ctrl]-P.  To get a list of all participants selected across all the consortium members, list the randoms for the consortium: on the main page choose the consortium in the drop down list of consortia and click the list randoms icon for the selected consortium.

You will find other report options on the page. With every report option to print a hard copy type [Ctrl]-P.

DrugTestNetwork/RandomWare features comprehensive random selection utilities to pick participants for drug and alcohol testing to comply with drug free workplace policies or to stay in compliance with US DOT (Department of Transportation) regulations.  The application features resources to generate random selections from stand alone pools or a consortium of multiple companies. Specify annual percentage targets, for stand alone pools or consortia, and the the random selection control will automatically keep the selections on track so you will hit the annual target of participants required for both the drug and the alcohol tests.

 

DOT MIS Analytics Report

Run the DOT MIS Analytics Report Before the DOT MIS Report

The DOT MIS Report only counts test results that match specific MIS reporting rules.
Some test results may get counted because the Reason for Testing,
Overall Qualitative Result, DOT status, Mode/Category, random
selection link, or canceled-test settings do not conform to MIS requirements.

The DOT MIS Analytics / Validation Report helps you find those
records before running the final DOT MIS Report.

To run the report for an individual account, search for the company and tap the report icon   for the account.and from the list as shown here:

To run the report for a consortium, on the main page, choose the consortium in the drop-down and tap the report icon  on the right:

When the page opens set the year the report covers.

Lower on the page, tap the report option:
DOT MIS Report Analytics: Show ONLY Tests that DO NOT conform …

  • Open the DOT MIS Analytics / Show ONLY Test that DO NOT conform …
    Run the Analytics Report for the year and month range specified.
  • Review tests marked an invalid and resolve the issues
    The report lists collected tests in the selected period and identifies
    records that may not be counted correctly on the MIS Report.
  • Check the “Reason Invalid” message
    Each invalid record explains why it does not conform. Common issues include:

    • Missing or invalid Reason for Testing
    • Missing or invalid Substance result
    • Missing or invalid Alcohol result
    • Missing Mode or Category
    • Mode/Category inconsistent with the selected account or consortium
    • Random test linked to the wrong selection or consortium
    • Canceled test missing either the CANCEL result code or the canceled checkbox
  • Edit the test result as needed
    Use the edit icon next to the record to correct the Reason for Testing,
    Overall Qualitative Result, canceled-test setting, DOT status, Mode, or Category.
  • Re-run the Analytics Report
    After corrections are made, run the Analytics Report again to confirm that
    the records now conform to the DOT MIS Report requirements.
  • Run the DOT MIS Report
    Once the Analytics Report no longer shows invalid records, run
    the DOT MIS Report with greater confidence that the report counts are accurate.

Key reminder

The Analytics Report does not replace the DOT MIS Report. It is a review tool
that helps identify records that may be excluded or counted incorrectly before
the official MIS report is generated.

DrugTestNetwork features automatic generation of the DOT MIS Report for Consortia, member participation, and stand alone accounts.  Users will also find complete analytic reports to confirm all reported test results conform to the requirements of the DOT MIS Report and includes data management tools to resolve any issue.

Users will also find resources to send every DOT account its MIS Report in a single request using the MIS Kiosk feature.

Add / Remove Participants

To manage participants (company employees, drivers, persons eligible for random selection, etc.) search for the company and tap the people icon to manage the account’s participants:

DOT account: tap the people icon with a shield.
Non-DOT account:  you will see a people icon without a shield.

A pop-up page will open where you can search for a person by name or list all participants by status: Active, Not Active, Pending:

  Click the Active icon to list all active participants.
  Click the Not icon to list all Not-Active Participants.
  Click the ALL icon to list Active, Not-Active, and Pending Participants.
  Click the clock to list Pending Participants.
  Click the Plus icon to add a new participant.
  You can also search for participants by name.

When you list or search for participants you’ll have a number of options to choose from: tap on an icon. If you hover the mouse over an icon a “tool-tip” displays that offers a brief description of the option.

 Open Participant’s Dashboard
 Open the Profile Editor to manage profile details, change status: Active, Not-Active, Pending

Participants with the status Not-Active or Pending are not included in the list for random selection.  A participant might be added as “Pending” if that person has not yet been hired; their status can be changed to “Active” once hired and engaged in safety sensitive duties.  A person with Not-Active status is someone who may have been terminated and no longer works for the company. For random selection purposes, only Active participants are included in random selections and contribute to the average number of participants, calculated across all random selections conducted, for a calendar year,  for the account or the consortium if the account is a member.

Newsletter: Send Update Participant Roster Announcements

Use the Newsletter to Send each account their Current Participant List Prior to Random Selections

Before running a random selection, it’s important that client accounts have an up-to-date participant list. The Newsletter feature in DrugTestNetwork (DTN) allows you to easily send a message to multiple accounts at once with options to include their current personnel roster so it can be reviewed and updated.

Best Practice: Send this reminder a few days before generating a random selection to give clients time to make updates.

Access the Newsletter Feature

  1. Go to the Utilities menu
  2. Select Newsletter Utilities

Step 1: Enter the Email Subject and Message

  • Enter a clear Subject Line (required)
  • Compose your message
Suggested Subject: Review & Update Your Participant List
Suggested Message: Review your current participant list included here and make any necessary updates prior to the upcoming random selection. Ensuring your roster is accurate helps maintain compliance and prevents missed selections.

Step 2: Choose Who Will Receive the Email

After the sections Message and Closing Statement, you’ll see the section: Indicate the Extent of the Broadcast.  To send the email to a consortium, select Only Selected Consortium, and choose the consortium in the drop-down.

Tip: Use the selected consortium option when preparing a random selection for that specific group.

Step 3: Include the Participant List

The newsletter allows you to include each account’s current personnel roster directly in the email.

Select one of the following options:

  • Active — Only currently active participants
  • Active & Pending — Includes participants not yet fully active
  • ALL — Includes Active, Pending, and Not-Active participants
Important: The participant list cannot be sent when the extent of the email is Everyone - some client contacts (reps) may not be assigned to an account and a list cannot be determined in these cases.

Step 4: Preview or Count Recipients

Before sending, you have options to verify your email:

  • Preview (Show) — Opens a preview of the email
  • Count — Displays how many recipients will receive the message
Recommended: Always preview your message to confirm the message before sending.

Step 5: Send the Newsletter

Once everything looks correct:

  • Confirm recipients and participant inclusion settings
  • Review your message content
  • Proceed with sending the email

Workflow Tip: Preparing for Random Selection

Recommended Workflow:

  1. Send the newsletter requesting participant updates
  2. Allow time for client accounts to review and update their rosters
  3. Verify key accounts if needed
  4. Run the random selection with confidence that your data is current

Final Tip

Using the newsletter feature for participant updates is one of the most efficient ways to communicate with multiple accounts at once. A quick reminder before each random selection helps improve accuracy, compliance, and overall program quality.

SAP/EAP Follow-Up Randon Periodic Drug Testing

Random Periodic Drug Testing Strategies: Individual, Color-Coded, and Horizon-Based Scheduling

In modern drug and alcohol testing programs—particularly those supporting rehabilitation, drug court, family court, DOT compliance, and employee assistance programs—effective scheduling is critical. Testing must be random, defensible, scalable, and operationally practical.

Often, scheduling approaches often fall short when programs expand or when participant requirements vary. DrugTestNetwork (DTN) introduces a comprehensive framework that automatically generates periodic testing dates to adapt to multiple program models, ensuring both compliance and efficiency.

This article outlines the core scheduling methodologies available within DTN, including:

  • Individually scheduled periodic testing
  • Color-coded group testing
  • Fixed-date program scheduling
  • Open-ended horizon-based scheduling
  • Constraint-based randomization and failure handling

1. Individually Scheduled Periodic Testing

Individually scheduled testing generates a unique set of randomized test dates for each participant based on defined parameters:

  • Frequency (nDays) — number of required tests
  • Timeframe — number of days in the testing window

For example, a 2/14 configuration requires two test dates within every 14-day window. Each participant’s schedule is generated independently, ensuring:

  • Maximum randomness
  • Even distribution of testing volume
  • Reduced risk of predictable patterns

This model is particularly effective when participants report to a single clinic or limited number of collection sites, as it prevents operational bottlenecks caused by concentrated testing volume.


2. Color-Coded Testing (Group Scheduling)

Color-coded testing introduces a group-based scheduling model where a predefined set of randomized dates is generated for a Color Code (e.g., Red, Blue, Green).

Participants assigned to a color inherit that color’s schedule, meaning:

  • All participants with the same color test on the same dates
  • Administrative overhead is significantly reduced
  • Scheduling becomes standardized across groups

This model is highly effective in distributed environments where participants report to multiple clinics across a region, city, or state. However, it requires careful planning when participants share a single collection site, as simultaneous testing requirements may exceed capacity.


3. Fixed-Date Program Scheduling (Start/End Defined)

Many rehabilitation and court-ordered programs operate within a defined enrollment period. DTN supports fixed-date scheduling based on:

  • Program Start Date
  • Program End Date

Within this window, the system generates all required test dates according to the participant’s frequency and timeframe configuration.

This approach ensures:

  • Full coverage of the program duration
  • Compliance with court or clinical requirements
  • Clear visibility into all upcoming obligations

Fixed-date scheduling is commonly used in:

  • Drug court programs
  • Family court monitoring
  • Structured rehabilitation timelines

4. Open-Ended Scheduling with Extended Horizons

Not all participants have a defined program end date. For these cases, DTN introduces horizon-based scheduling, where test dates are generated forward into the future without requiring a fixed end date.

A configurable horizon (e.g., 90 days, 6 months) ensures that participants always have upcoming scheduled tests while avoiding unnecessary long-term projections.

With Nightly Extension enabled:

  • The system automatically extends future dates as time progresses
  • Participants never “run out” of scheduled tests
  • Administrative intervention is minimized

Additional logic prevents excessive generation by skipping participants whose schedules already extend sufficiently into the future.


5. Dynamic Rescheduling and Parameter Changes

When a participant’s testing requirements change—such as frequency or timeframe—DTN treats the update as a new scheduling profile.

The system:

  • Deletes all future scheduled dates (typically from tomorrow forward)
  • Regenerates dates using the updated parameters

This ensures:

  • Consistency with current program requirements
  • No overlap or conflict with prior scheduling logic
  • Clean transition between testing protocols

6. Constraint-Based Randomization

DTN’s scheduling engine incorporates real-world constraints to ensure both compliance and practicality:

  • Exclusion of specific days (e.g., weekends or holidays)
  • Exception calendars (e.g., clinic closures, holidays)
  • Non-consecutive day rules
  • Daily capacity balancing across participants

These constraints are applied during date generation to produce schedules that are both random and operationally viable.


7. Failure Handling and Audit Transparency

In certain scenarios, it may not be mathematically possible to generate all required test dates within a timeframe due to constraints.

Rather than failing silently, DTN:

  • Logs the issue with detailed reason codes
  • Continues generating remaining viable dates
  • Provides reporting for administrative review

This ensures transparency and allows program managers to take corrective action when necessary.


8. Operational Efficiency and Industry Impact

The combination of individual scheduling, color-coded grouping, and horizon-based automation positions DTN as a comprehensive solution for modern testing programs.

Key benefits include:

  • Scalable scheduling across thousands of participants
  • Reduced administrative overhead
  • Improved clinic load management
  • Enhanced compliance with regulatory and judicial requirements
  • Defensible randomization methodologies

Whether managing a small rehabilitation program or a large multi-site testing network, DTN provides the flexibility and control required to maintain both efficiency and integrity.


Conclusion

Periodic drug and alcohol testing is no longer a one-size-fits-all process. Programs vary in size, structure, geography, and compliance requirements.

By supporting multiple scheduling strategies—including individual randomization, group-based color coding, fixed program timelines, and automated horizon extension—DTN enables organizations to design testing protocols that align with their operational realities.

This flexibility, combined with robust constraint handling and audit transparency, establishes DTN as a leading platform in the drug testing and rehabilitation monitoring industry.

Participant List: eMail to Contact / DER

Sending a Participant List to a DER (Designated Employee Representative)

Keeping your clients informed is an important part of managing your program in DTN. You can quickly send a participant list to each company’s Designated Employee Representative (DER) — either in the email body or as a CSV attachment.


Step-by-Step: Send a Participant List

  1. Search for the Company
  2. Click the Email Personnel icon 
  3. Select the Recipient(s)
    Contacts for the company will appear with checkboxes.Ensure the DER is selected.Select additional contacts if needed.

Choose Which Participants to Include

Select the scope of participants to include in the list:

  • Active — Only currently active participants
  • Active & Pending — Includes participants not yet fully active
  • ALL — Includes Active, Pending, and Not-Active participants
Tip: Choose the option that best fits what your client needs to review. Most DERs prefer Active or Active & Pending.

Choose How to Send the List

  • Include in Email Body
    The participant list appears directly in the email message.Best for quick viewing.
  • Attach as CSV File
    Adds a downloadable spreadsheet file.Ideal for sorting and filtering.

Optional: Add Additional Recipients

You are not limited to saved contacts.

  • Enter a name and email address manually to include someone not listed
  • Add yourself to preview the email before sending
Preview Tip: Sending the email to yourself first is a great way to confirm formatting and content before delivering it to your client.

Use an Email Template (Recommended)

Save time by creating a reusable email template instead of writing messages from scratch each time.

To create or edit a template:

  1. Go to the Other-Data menu
  2. Select Mail/Text Messages & Other Documents
  3. Choose Current Personnel Roster
Efficiency Tip: Create a standard message for participant lists and simply make small edits before sending. This can save significant time when working with multiple clients.

Final Step: Review and Send

Before sending, confirm the following:

  • Correct recipients are selected
  • Participant scope is correct (Active, Active & Pending, or ALL)
  • Message content is accurate
  • List format is correct (email body or CSV attachment)
Final Tip: A quick review helps ensure your message is clear, accurate, and professional before sending.

Drug Classes and their included Substances

Here are some drug classes and what they may include. In DTN, a “drug class” can be a broad category, while the items listed beneath it are the specific substances (or reportable analytes) a lab may report under that class.

  • 6-Acetylmorphine
    • 6-Acetylmorphine
  • Amphetamine / Methamphetamine
    • Methamphetamine
    • Amphetamine
  • Benzoylecgonine-Cocaine Metabolite
    • Benzoylecgonine-Cocaine Metabolite
  • Hydrocodone / Hydromorphone
    • Hydrocodone/Hydromorphone
    • Hydromorphone
    • Hydrocodone
  • MDMA/MDA
    • MDA-Methylenedioxyamphetamine
    • MDMA-Methylenedioxymethamphetamine
  • Codeine / Morphine
    • Morphine
    • Codeine
  • Oxycodone / Oxymorphone
    • Oxymorphone
    • Oxycodone
  • Phencyclidine
    • Phencyclidine
  • Marijuana Metabolite
    • Marijuana Metabolite
  • Barbiturates
    • Amobarbital
    • Phenobarbital
    • Secobarbital
    • Butalbital
    • Butabarbital
    • Pentobarbital
  • Benzodiazepines
    • Oxazepam
    • Nordiazepam
    • Temazepam
    • Alpha-hydroxyalprazolam
    • Lorazepam
    • 7-Aminoclonazepam
  • Methamphetamine Isomers
    • D-Methamphetamine
    • L-Methamphetamine
  • Methadone
    • Methadone Metabolite- eddp
    • Methadone
  • Extended Opiates (4)
    • Morphine
    • Codeine
    • Hydromorphone
    • Hydrocodone
  • Propoxyphene
    • Propoxyphene
    • Norpropoxyphene
  • Ethanol
    • Ethanol
  • Creatinine
    • Class: Validation
  • Ethyl Glucuronide
    • Ethyl Glucuronide
    • Ethyl Sulfate
  • Methaqualone
    • Methaqualone
  • Ph
    • Class: Validation
  • Extended Benzodiazepines
    • Extended Benzodiazepines
    • Nordiazepam
    • Oxazepam
    • Temazepam
    • 7-Amino Flunitrazepam (flunitrazepam metabolite)
    • 2-Hydroxy Ethylflurazepam (flurazepam metabolite)
    • Lorazepam
    • Alpha-Hydroxymidazolam
    • Alpha-Hydroxyalprazolam
    • 7-Aminoclonazepam
    • Alpha-hydroxytriazolam
  • Hydrocodone / Hydromorphone
    • Hydrocodone/Hydromorphone
    • Hydromorphone
    • Hydrocodone

Panels, Drug Classes and Reportable Substances

Understanding Drug Classes and Reportable Substances in DTN

Using Amphetamines and Barbiturates as examples

DrugTestNetwork (DTN) reports drug test results based on Panels, which are defined sets of substances that appear on a test report. To support the wide variation in how laboratories report results—and how users want to present them—DTN separates drug classes from reportable substances
and allows flexible panel configuration.

This tutorial explains how those pieces work together and how different reporting styles affect the final report.


Core Concepts

Panels

A Panel is a record in the Panels table and includes:

  • Panel Name (abbreviation) – e.g., 5DSP
  • Description – the full panel name as referred to by the lab

Panels define what may appear on a report, not necessarily what must appear.

Drug Classes

A Drug Class is a logical grouping of related substances (for example,
Amphetamines or Barbiturates).

  • Drug classes provide grouping and interpretation
  • Drug classes may or may not be directly reportable
  • A drug class can contain one or many related substances

Every reportable substance must be associated with one drug class.

Reportable Substances

A reportable substance is an item that can appear as its own line on a report with a  Positive or Negative result.

Important points:

  • A reportable substance must be associated with a drug class
  • A drug class may also be reportable
  • Panels can include:
    • Only the drug class
    • Only specific substances
    • Both the class and its substances

This flexibility allows DTN to adapt to different lab reporting formats and user preferences.


Example 1: Amphetamines

Drug Class Structure

Drug Class: Amphetamines

Associated Substances: Amphetamine, Methamphetamine

Labs commonly report results as:

Amphetamines: Negative

…even though the testing actually evaluates Amphetamine and Methamphetamine separately.  DTN supports several valid panel configurations.

Panel Configuration Options

Option A: Drug Class Only

Panel includes:

  • Amphetamines

Result behavior:

Report shows only:

Amphetamines: Positive / Negative

If the user is manually entering results and knows the specific substance:

  • Amphetamine or Methamphetamine may be added to the report manually
  • This does not require them to be part of the original panel

Option B: Individual Substances Only

Panel includes:

  • Amphetamine
  • Methamphetamine

Result behavior:

Amphetamine: Positive
Methamphetamine: Negative

No overall “Amphetamines” line appears unless it was explicitly added to the panel.

Option C: Class + Substances

Panel includes:

  • Amphetamines
  • Amphetamine
  • Methamphetamine

Example result (Amphetamine positive):

Amphetamines: Positive
Amphetamine: Positive
Methamphetamine: Negative

This mirrors many lab reports and provides full transparency.

Key Amphetamines Rule

If any included substance is positive:

  • The drug class may also be reported as Positive
  • Whether negative component substances appear depends on:
    • Panel definition
    • Lab EDI data
    • User reporting preferences (manual entry)

Example 2: Barbiturates

Drug Class Structure

Drug Class: Barbiturates

Associated Substances: Amobarbital, Phenobarbital, Secobarbital, Butalbital, Butabarbital, Pentobarbital

This is a common case where users often want simpler reporting.

Typical Panel Setup

Panel includes:

  • Barbiturates

Default result:

Barbiturates: Negative

None of the individual substances appear unless needed.

Reporting a Specific Positive

If, for example, Amobarbital is positive:

  • Amobarbital must already exist as a reportable substance in DTN
  • It must be associated with the Barbiturates drug class
  • The user can then add it during result entry

Result may show:

Barbiturates: Positive
Amobarbital: Positive

Optional Simplification

If the user prefers:

  • They may remove Barbiturates from the report
  • Leaving only:
Amobarbital: Positive

DTN allows this so reports can match employer preferences, MRO guidance, or historical reporting formats.


Electronic Results (EDI) vs Manual Entry

EDI Results

When results are received electronically via EDI (Electronic Data Interchange):

  • Labs may send:
    • Drug class only
    • Drug class + positive substances
    • Drug class + both positive and negative components
  • DTN stores and reports exactly what the lab sends

Different labs behave differently—even for the same substances.

Manual Entry

When entering results manually:

  • Users may choose their reporting style
  • Drug classes and substances can be:
    • Added
    • Removed
    • Marked Positive or Negative independently
  • This allows correction, clarification, or simplification when needed

Design Principles Behind DTN’s Model

DTN intentionally separates:

  • Drug classes (logical grouping)
  • Reportable substances (what appears on reports)

This design:

  • Supports inconsistent lab reporting
  • Prevents forced over-reporting
  • Allows minimal or detailed reports
  • Keeps regulatory and clinical accuracy intact

Summary

  • Every reportable substance belongs to a drug class
  • Drug classes may or may not be reportable
  • Panels define what can appear, not what must appear
  • Users control reporting detail—especially during manual entry
  • Amphetamines show how classes and components may overlap
  • Barbiturates show why classes are often reported alone

This flexibility is essential for real-world drug testing workflows.

NOTE: You will find management features for Panels, Drug Classes and Reportable Items under the Other-Data menu.

Refer to sections:

  • Test Panels & Other Services
  • Reporting Classifications, Substances, Analytes, Metabolites & Validation Tests